Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 22 of 39

  1. venetoclax

    VENCLEXTA AbbVie

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01XX52
  2. vericiguat

    VERQUVO Bayer Australia Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    C01
  3. verteporfin

    VISUDYNE

    INJECTION FDA: approved Β· EMA: approved

    S01LA01
  4. vibegron

    OBGEMSA

    ORAL FDA: approved Β· EMA: approved

    G04BD15
  5. vimseltinib

    ROMVIMZA

    ORAL FDA: approved Β· EMA: approved

    L01EX
  6. vismodegib

    ERIVEDGE Hoffmann-La Roche

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L01XX43
  7. vorasidenib

    VORANIGO

    ORAL FDA: approved Β· EMA: approved

    L01XM04
  8. vortioxetine

    BRINTELLIX

    ORAL FDA: approved Β· EMA: approved

    N06AX26
  9. zanamivir

    DECTOVA

    INHALATION FDA: approved Β· EMA: approved

    J05AH01
  10. zonisamide

    ZONEGRAN Amdipharm Mercury (Australia) Pty Limited

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    N03AX15
  11. zuranolone

    ZURZUVAE

    ORAL FDA: approved Β· EMA: approved

    N06A
  12. 13c-urea

    HELICOBACTER TEST INFAI

    EMA: approved

    V04CX
  13. 5-aminolevulinic acid hydrochloride

    AMELUZ

    EMA: approved

    L01XD04
  14. abiraterone

    ABIRATERONE DR.REDDY''S Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L02BX03
  15. aclidinium

    BRETARIS GENUAIR A.Menarini Australia Pty Limited

    EMA: approved Β· TGA: approved

    R03AL05
  16. acoramidis

    BEYONTTRA

    EMA: approved

    C01EB25
  17. adalimumab

    ABRILADA Pfizer Australia Pty Ltd

    FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AB04
  18. agomelatine

    VALDOXAN

    EMA: approved

    N06AX22
  19. albutrepenonacog alfa

    IDELVION

    EMA: approved Β· PMDA: approved

    B02BD04
  20. alectinib

    ALECENSA Hoffmann-La Roche

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01ED03
  21. alendronic acid

    VANTAVO (PREVIOUSLY ALENDRONATE SODIUM AND COLECALCIFEROL, MSD)

    EMA: approved

    M05BB03
  22. allogeneic umbilical cord-derived cd34- cells, non-expanded

    ZEMCELPRO

    EMA: approved

    B05AX04
  23. alpha1-proteinase inhibitor (human)

    RESPREEZA

    EMA: approved

    B02AB02
  24. amikacin

    ARIKAYCE LIPOSOMAL

    EMA: approved

    J01GB06

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.